A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.
about
Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for testicular germ cell tumorsPaclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor.Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomes.Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors.Canadian consensus guidelines for the management of testicular germ cell cancer.Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer.GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.Testis cancer.Management of metastatic germ cell tumors.A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update.Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.Efficacy and tolerability of TIP (paclitaxel, ifosfamide and cisplatin) incorporated into induction chemotherapy for patients with intermediate- or poor-risk metastatic germ cell tumors.Management of poor-prognosis testicular germ cell tumors.Hotspot TERT promoter mutations are rare events in testicular germ cell tumors.Role of post-chemotherapy radiation in the management of children and adolescents with primary advanced malignant mediastinal germ cell tumors.Saudi oncology society and Saudi urology association combined clinical management guidelines for testicular germ cell tumors.Is high-dose chemotherapy superior to conventional chemotherapy as first salvage treatment for patients with metastatic germ cell tumors?Importance of continuous sequential chemotherapy and multimodal treatment for advanced testicular cancer: a high-volume Japanese center experience.Consolidative high-dose chemotherapy after conventional-dose chemotherapy as first salvage treatment for male patients with metastatic germ cell tumours.Saudi Oncology Society clinical management guidelines for testicular germ cell tumorsHigh-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies.Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy.Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study.Systemic immune-inflammation index in germ-cell tumours.Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma.Absence of microsatellite instability and BRAF (V600E) mutation in testicular germ cell tumors.Conventional-Dose versus High-Dose Chemotherapy for Relapsed Germ Cell Tumors.A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study
P2860
Q26747761-EF200444-7602-458C-A506-C152ED070B7DQ30421124-FE9D8E22-0045-402F-8EE7-BF9F526C3E72Q33409143-534408E0-3513-46F5-89D0-9DB810A4C740Q33418686-298CDE04-1C6A-4BEA-A9B7-EAF5726348FBQ33753786-3C4DDC45-9090-4A72-B5C1-EF91412B2610Q34886445-7015636F-5E49-4663-931F-36D11EE98A05Q36610888-75311103-5B5C-4BE0-BF6D-6EF9D803322DQ36960850-06025AD2-69B2-4769-B9CA-750CEAFDF1CAQ37159527-E748C954-02E5-48FE-BCF8-F695079ABD94Q37875412-D804AAD3-229B-4E0A-8574-CD15F9D52DF3Q37882776-A23B1B7A-4EC7-4AD9-91F8-3075396ECDF8Q37905875-817C7E62-6B41-408D-8AB1-E13DB0B87983Q38012658-007C76D7-CE34-4789-B207-D41707186F1DQ38666300-20766D5D-B1E6-47F7-8192-C62FBD984A51Q38966419-F44E30B9-D454-4058-A028-4C2AE85E4F35Q39108772-C74C8109-8CEA-411B-B775-CAF5C2232B5CQ40810851-DCF2887B-B97D-42FE-8CF0-E40CE8FA7F94Q41156947-53F341CF-48AE-403A-B4CB-57A6F9C228F9Q41432888-3F584D28-1FA9-46DE-9835-CE3B71A07BD8Q42012376-8A6AE8C6-A1FD-49B7-A428-31391AE739C7Q42059585-F9E3E894-810C-48C8-8EAA-42ADBD0A49ADQ42141279-FF3BD2ED-A320-4515-BF73-3BB5DB3A3EFBQ42541835-9BA6D6C8-0A04-4F0A-B909-32A4DE418E47Q42737407-94F66046-5A20-4121-969C-68F1A0606AC8Q43263026-9D891923-5703-49FD-8FF9-98130C6DDF66Q49017342-36EC3F42-926D-47C9-A319-726689A3A76BQ49937793-01C1160B-A02A-470A-B4D4-3D1CB28DD594Q52561899-5EAECCB5-4282-44B3-8E1D-44C90EFD6947Q52683145-953092B8-8C7C-40D5-82E2-E6B91ACD4029Q52981291-D7F57C54-D042-45D5-A3EA-DB3D9037E5E5Q55023089-53E69CB6-9430-4D31-8653-D3B665B5B1E6Q55097039-6E14BB02-2A05-4B7D-935F-AB5FDF5BE448Q57579466-BD17E9DC-F935-4FBE-BC4C-C21C35C6D4C4
P2860
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A phase II trial of TIP (pacli ...... edical research council trial.
@ast
A phase II trial of TIP (pacli ...... edical research council trial.
@en
type
label
A phase II trial of TIP (pacli ...... edical research council trial.
@ast
A phase II trial of TIP (pacli ...... edical research council trial.
@en
prefLabel
A phase II trial of TIP (pacli ...... edical research council trial.
@ast
A phase II trial of TIP (pacli ...... edical research council trial.
@en
P2093
P2860
P356
P1476
A phase II trial of TIP (pacli ...... edical research council trial.
@en
P2093
G J S Rustin
M H Cullen
MRC Testicular Tumour Working Party
S P Stenning
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602682
P407
P577
2005-07-01T00:00:00Z